Monument Capital Management Has $3.33 Million Position in Cardinal Health, Inc. $CAH

Key Points

• Monument Capital Management increased its holdings in Cardinal Health by 356% in Q2, owning nearly 20,000 shares valued at approximately $3.33 million.
• CEO Jason M. Hollar sold over 107,000 shares of Cardinal Health, reflecting a 31.35% decrease in his ownership stake, while other insiders also traded significant amounts of stock.
• Cardinal Health's recent earnings report showed a beat on EPS estimates, reporting $2.08 per share, and announced a quarterly dividend of $0.5107 to be paid on October 15.

Monument Capital Management raised its holdings in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 356.0% in the 2nd quarter, according to its most recent 13F filing with the SEC. The fund owned 19,793 shares of the company's stock after acquiring an additional 15,452 shares during the period. Monument Capital Management's holdings in Cardinal Health were worth $3,325,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. JPMorgan Chase & Co. lifted its stake in Cardinal Health by 40.0% in the first quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company's stock valued at $575,327,000 after buying an additional 1,193,983 shares during the period. Northern Trust Corp boosted its stake in Cardinal Health by 3.5% during the 1st quarter. Northern Trust Corp now owns 3,143,003 shares of the company's stock worth $433,012,000 after acquiring an additional 105,154 shares during the last quarter. Wellington Management Group LLP grew its holdings in Cardinal Health by 1,666.7% during the first quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company's stock valued at $328,470,000 after purchasing an additional 2,249,241 shares during the period. Price T Rowe Associates Inc. MD increased its stake in Cardinal Health by 3.3% in the first quarter. Price T Rowe Associates Inc. MD now owns 1,654,036 shares of the company's stock valued at $227,877,000 after purchasing an additional 52,714 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its holdings in Cardinal Health by 0.6% in the first quarter. Dimensional Fund Advisors LP now owns 1,246,788 shares of the company's stock worth $171,749,000 after purchasing an additional 7,940 shares during the period. 87.17% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, CEO Jason M. Hollar sold 107,705 shares of the stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.90, for a total transaction of $16,037,274.50. Following the completion of the transaction, the chief executive officer directly owned 235,901 shares in the company, valued at $35,125,658.90. This represents a 31.35% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Michelle D. Greene sold 13,500 shares of the firm's stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $2,009,070.00. Following the completion of the transaction, the insider owned 14,976 shares of the company's stock, valued at $2,228,728.32. The trade was a 47.41% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 271,676 shares of company stock valued at $40,489,525 in the last quarter. Company insiders own 0.12% of the company's stock.

Cardinal Health Price Performance

Shares of Cardinal Health stock opened at $157.24 on Friday. The firm has a market cap of $37.36 billion, a price-to-earnings ratio of 24.38, a price-to-earnings-growth ratio of 1.33 and a beta of 0.71. The stock's 50-day moving average is $152.07 and its 200-day moving average is $150.92. Cardinal Health, Inc. has a one year low of $106.98 and a one year high of $168.44.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The business had revenue of $60.16 billion for the quarter, compared to analyst estimates of $60.91 billion. During the same quarter last year, the firm earned $1.84 EPS. Cardinal Health's revenue for the quarter was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, equities analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be issued a dividend of $0.5107 per share. The ex-dividend date is Wednesday, October 1st. This represents a $2.04 annualized dividend and a yield of 1.3%. Cardinal Health's dividend payout ratio is presently 31.63%.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on CAH shares. UBS Group reissued a "buy" rating on shares of Cardinal Health in a report on Tuesday, August 12th. Argus set a $189.00 target price on Cardinal Health in a research note on Friday, August 22nd. Wells Fargo & Company restated an "overweight" rating and issued a $185.00 price target (up from $183.00) on shares of Cardinal Health in a report on Wednesday, August 13th. Wall Street Zen cut Cardinal Health from a "strong-buy" rating to a "buy" rating in a report on Saturday, August 2nd. Finally, Weiss Ratings reissued a "buy (b)" rating on shares of Cardinal Health in a research note on Wednesday. Twelve equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $166.00.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.